SINTOFARM SA BUCURESTI
SINT
|
|
Healthcare
Financial Reports
Price Chart
Evoluție Istorică (Fundamente)
Cum au evoluat metricile cheie an de an - ca să vezi dacă SINT crește, stagnează sau se deteriorează, nu doar cum arată azi.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 TTM | 2026 TTM | Tendință |
|---|---|---|---|---|---|---|---|---|
| P/E Ratio ⓘ | 13.22 | 8.41 | 34.23 | — | 41.32 | 135.77 | — | ▼ +122.55 |
| ROE ⓘ | 4.49% | 6.86% | 4.68% | -2.17% | 3.09% | 3.09% | -4.98% | ▼ -9.48% |
| Datorie / Capital Propriu ⓘ | 0.20 | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | — | ▲ -0.01 |
Precizie Prognoză (Istoric)
Cât de aproape au fost estimările trecute de creștere/valoare justă față de ce s-a întâmplat de fapt.
Nicio prognoză înregistrată încă pentru această companie.
Sector: Healthcare
Based on Market CapETAPA 1 • MUST HAVE
1/8
Healthy Leverage (Debt/Equity) ⓘ
0.00
țintă < 1.5
Gross Margin vs Industry ⓘ
0.0% vs 5.6%
țintă > 5.6%
Operating Cash Flow vs Profit ⓘ
N/A
țintă > 100%
Free Cash Flow vs Profit ⓘ
N/A
țintă > 80%
ROIC (Return on Capital) ⓘ
0.00%
țintă Positive
ROIC vs WACC ⓘ
ROIC: 0.0% / WACC: 9.4%
țintă > WACC
ROE (Return on Equity) ⓘ
0.0%
țintă > 10%
EBITDA Positive ⓘ
0.00M
țintă > 0
ETAPA 2 • CRITERII
1/12Interest Coverage ⓘ
N/A
țintă > 3x
N/A
Net Margin vs Industry ⓘ
0.0%
țintă > 1.6%
Miss
ROA vs Industry ⓘ
0.0%
țintă > 3.1%
Miss
Current Ratio ⓘ
N/A
țintă > 1.5
N/A
Assets Growth (5y) ⓘ
N/A
țintă > 0%
N/A
FCF CAGR (5y) ⓘ
N/A
țintă > 5%
N/A
EV/EBITDA vs Industry ⓘ
0.0 vs 0.7
țintă < Industry
Miss
Net Debt / EBITDA ⓘ
0.00
țintă < 3
Passed
Revenue CAGR (5y) ⓘ
N/A
țintă > 5%
N/A
Quick Ratio ⓘ
N/A
țintă > 1.0
N/A
Payout Ratio (Dividend) ⓘ
N/A
țintă < 80%
N/A
EBITDA Margin vs Industry ⓘ
N/A
țintă > 2.5%
N/A
SNAPSHOT COMPANIE
SELL
20% încredere
Etapa 1: 17%
• Etapa 2: 25%
Semnal algoritmic bazat pe fundamentale, nu recomandare de investiție.
Capitalizare ⓘ
0.00B RON
EBITDA ⓘ
0.00M
P/E Ratio ⓘ
0.00
PEG Ratio ⓘ
0.00
Dividend Yield ⓘ
0.00%
Beta ⓘ
1.78
Valoare Intrinsecă (Graham) vs. Preț Curent ⓘ
Preț Curent
0.00 RON
Valoare Graham
0.00 RON
Supraevaluare
0.0%
financial report
Annual Data| Metric | TTM | 2025 | TTM | 2025 | 2024 |
|---|---|---|---|---|---|
| Fiscal Year | 2,026 | 2,025 | 2,025 | 2,024 | 2,023 |
| Fiscal Quarter | H1 | H2 | H2 | H2 | H2 |
| Marketcap | 42,468,404 | 13,512,674 | 44,398,786 | 20,848,126 | 16,678,500 |
| Enterprise Value | 40,519,044 | 12,711,804 | 44,682,826 | 20,769,995 | 16,422,330 |
| Last Close Ratios | 1,100.00% | 350.00% | 1,150.00% | 540.00% | 432.00% |
| Pe | - | 41.32 | 135.77 | - | 34.23 |
| PS Ratio | 3.55 | 1.05 | 3.45 | 1.69 | 1.45 |
| PB Ratio | 4.18 | 1.26 | 4.12 | 2.00 | 1.56 |
| P/TBV Ratio | 4.36 | 1.27 | 4.16 | 2.02 | 1.58 |
| P/FCF Ratio | - | - | - | 42.26 | 51.30 |
| P/OCF Ratio | - | - | - | 30.27 | 38.36 |
| Evrevenue | 3.39 | 0.99 | 3.47 | 1.68 | 1.43 |
| EV/EBITDA Ratio | 180.82 | 11.90 | 41.84 | 40.03 | 13.51 |
| EV/EBIT Ratio | - | 21.82 | 76.71 | 621.88 | 22.54 |
| EV/FCF Ratio | - | - | - | 42.10 | 50.52 |
| Debtequity | - | 0.19 | 0.19 | 0.19 | 0.19 |
| Debt / EBITDA Ratio | - | 1.86 | 1.86 | 3.83 | 1.63 |
| Debt / FCF Ratio | - | - | - | 4.03 | 6.11 |
| Net Debt / Equity Ratio | -0.19 | 0.03 | 0.03 | 0.12 | 0.15 |
| Net Debt / EBITDA Ratio | -8.70 | 0.27 | 0.27 | 2.48 | 1.30 |
| Net Debt / FCF Ratio | - | - | - | 2.61 | 4.87 |
| Asset Turnover | 84.30% | 89.60% | 89.60% | 86.60% | 80.80% |
| Inventory Turnover | 107.10% | 104.50% | 104.50% | 85.40% | 90.70% |
| Quick Ratio | 1.89 | 2.08 | 2.08 | 1.83 | 1.82 |
| Current Ratio | 2.86 | 2.95 | 2.95 | 2.84 | 2.79 |
| Roe | -4.98% | 3.09% | 3.09% | -2.17% | 4.68% |
| Return on Assets (ROA) | -1.37% | 2.53% | 2.53% | 0.15% | 3.20% |
| Return on Invested Capital (ROIC) | -3.79% | 4.41% | 4.54% | 0.28% | 6.01% |
| Return on Capital Employed (ROCE) | -0.03 | 0.05 | 0.05 | 0.00 | 0.07 |
| Earningsyield | -1.22% | 2.42% | 0.74% | -1.10% | 2.92% |
| FCF Yield | - | - | - | 2.37% | 1.95% |
Price History
Oct 12, 2023 — Jun 03, 2026
41 Records
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-06-03 | 9.40 | 9.40 | 9.40 | 9.40 | 1 |
| 2026-05-27 | 8.40 | 9.95 | 8.40 | 9.90 | 402 |
| 2026-05-26 | 6.75 | 8.00 | 6.75 | 8.00 | 102 |
| 2026-05-20 | 6.70 | 6.70 | 6.70 | 6.70 | 10 |
| 2026-04-23 | 6.55 | 6.55 | 6.55 | 6.55 | 2 |
| 2026-04-17 | 6.50 | 6.50 | 6.50 | 6.50 | 500 |
| 2026-04-14 | 9.10 | 9.10 | 9.10 | 9.10 | 50 |
| 2026-03-26 | 7.00 | 7.00 | 7.00 | 7.00 | 40 |
| 2026-03-13 | 10.00 | 10.00 | 9.95 | 9.95 | 1,100 |
| 2026-03-12 | 6.45 | 9.95 | 6.45 | 9.95 | 73 |
| 2026-03-04 | 9.15 | 9.15 | 9.15 | 9.15 | 27 |
| 2026-03-03 | 8.40 | 8.40 | 8.40 | 8.40 | 20 |
| 2026-02-26 | 8.40 | 9.00 | 8.40 | 9.00 | 18 |
| 2026-02-23 | 6.95 | 6.95 | 6.95 | 6.95 | 3 |
| 2026-02-17 | 6.90 | 7.25 | 5.25 | 7.25 | 345 |
| 2026-02-16 | 7.50 | 7.50 | 7.50 | 7.50 | 10 |
| 2026-02-13 | 5.80 | 5.80 | 5.80 | 5.80 | 40 |
| 2026-02-11 | 4.60 | 5.40 | 4.60 | 5.40 | 101 |
| 2026-01-12 | 4.22 | 4.22 | 4.22 | 4.22 | 73 |
| 2025-11-11 | 3.50 | 3.50 | 3.50 | 3.50 | 1 |
| 2025-02-07 | 4.30 | 4.30 | 4.30 | 4.30 | 54 |
| 2025-01-31 | 5.20 | 5.20 | 5.20 | 5.20 | 15 |
| 2025-01-29 | 6.90 | 6.90 | 3.82 | 4.00 | 214 |
| 2024-10-30 | 5.40 | 5.40 | 5.40 | 5.40 | 40 |
| 2024-10-17 | 5.00 | 5.00 | 5.00 | 5.00 | 40 |
| 2024-10-16 | 4.70 | 4.70 | 4.70 | 4.70 | 47 |
| 2024-10-15 | 4.70 | 4.70 | 4.70 | 4.70 | 3 |
| 2024-06-14 | 4.80 | 4.80 | 4.80 | 4.80 | 6 |
| 2024-05-29 | 6.20 | 6.20 | 6.20 | 6.20 | 50 |
| 2024-05-27 | 5.50 | 5.50 | 5.50 | 5.50 | 39 |
| 2024-05-20 | 5.50 | 5.50 | 5.50 | 5.50 | 6 |
| 2024-05-09 | 5.50 | 5.50 | 5.50 | 5.50 | 64 |
| 2024-05-08 | 5.50 | 5.50 | 5.50 | 5.50 | 40 |
| 2024-04-29 | 4.80 | 4.80 | 4.80 | 4.80 | 40 |
| 2024-04-22 | 5.55 | 5.55 | 5.55 | 5.55 | 172 |
| 2024-02-08 | 5.55 | 5.55 | 5.55 | 5.55 | 50 |
| 2024-01-17 | 5.60 | 5.60 | 5.60 | 5.60 | 10 |
| 2023-11-14 | 4.32 | 4.32 | 4.32 | 4.32 | 40 |
| 2023-11-13 | 5.50 | 5.50 | 5.50 | 5.50 | 40 |
| 2023-10-17 | 4.40 | 4.50 | 4.40 | 4.50 | 50 |
| 2023-10-12 | 3.50 | 3.50 | 3.50 | 3.50 | 39 |